Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Diversity of cell phenotypes among MT-2 cell lines affects the growth of U937 cells and cytokine production.

Nomura H, Umekita K, Hashikura Y, Umeki K, Yamamoto I, Aratake Y, Saito M, Hasegawa H, Yanagihara K, Okayama A.

Hum Cell. 2018 Dec 17. doi: 10.1007/s13577-018-00231-3. [Epub ahead of print]

PMID:
30560508
2.

Detection of microbial genes in a single leukocyte by polymerase chain reaction following laser capture microdissection.

Yamada A, Umeki K, Saeki Y, Hashikura Y, Nomura H, Yamamoto I, Umekita K, Takajo I, Koshimoto C, Okayama A.

J Microbiol Methods. 2018 Dec;155:42-48. doi: 10.1016/j.mimet.2018.11.005. Epub 2018 Nov 10.

PMID:
30423364
3.

Development of a simple and practical method of discrimination between Vibrio furnissii and V. fluvialis based on single-nucleotide polymorphisms of 16S rRNA genes observed in V. furnissii but not in V. fluvialis.

Takajo I, Yamada A, Umeki K, Saeki Y, Hashikura Y, Yamamoto I, Umekita K, Urayama-Kawano M, Yamasaki S, Taniguchi T, Misawa N, Okayama A.

J Microbiol Methods. 2018 Jan;144:22-28. doi: 10.1016/j.mimet.2017.10.014. Epub 2017 Oct 27.

PMID:
29111399
4.

Evaluation of Line Immunoassay to Detect HTLV-1 Infection in an Endemic Area, Southwestern Japan; Comparison with Polymerase Chain Reaction and Western Blot.

Umeki K, Umekita K, Hashikura Y, Yamamoto I, Kubo K, Nagatomo Y, Okayama A.

Clin Lab. 2017 Feb 1;63(2):227-233. doi: 10.7754/Clin.Lab.2016.160501.

PMID:
28182361
5.

Infection of defective human T-lymphotropic virus type 1.

Hashikura Y, Umeki K, Umekita K, Nomura H, Yamada A, Yamamoto I, Hasegawa H, Yanagihara K, Okayama A.

Hum Cell. 2017 Apr;30(2):117-123. doi: 10.1007/s13577-016-0156-4. Epub 2017 Jan 9.

PMID:
28070874
6.

The diversity of the structure and genomic integration sites of HTLV-1 provirus in MT-2 cell lines.

Hashikura Y, Umeki K, Umekita K, Nomura H, Yamamoto I, Hasegawa H, Yanagihara K, Okayama A.

Hum Cell. 2016 Jul;29(3):122-9. doi: 10.1007/s13577-016-0136-8. Epub 2016 Mar 3.

PMID:
26940204
7.

Characterization of various types of mast cells derived from model mice of familial gastrointestinal stromal tumors with KIT-Asp818Tyr mutation.

Kajimoto N, Nakai N, Ohkouchi M, Hashikura Y, Liu-Kimura NN, Isozaki K, Hirota S.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):11970-82. eCollection 2015.

8.

Gastrointestinal stromal tumors with exon 8 c-kit gene mutation might occur at extragastric sites and have metastasis-prone nature.

Ito T, Yamamura M, Hirai T, Ishikawa T, Kanda T, Nakai T, Ohkouchi M, Hashikura Y, Isozaki K, Hirota S.

Int J Clin Exp Pathol. 2014 Oct 15;7(11):8024-31. eCollection 2014.

9.

Extracellular domain c-kit mutation with duplication of Ser501Ala502 found in gastrointestinal stromal tumors is more imatinib- and nilotinib-sensitive than that with duplication of Ala502Tyr503.

Liu NN, Ohkouchi M, Hashikura Y, Kajimoto N, Matsuda I, Isozaki K, Toh Y, Takahashi T, Nishida T, Hirota S.

Lab Invest. 2013 May;93(5):502-7. doi: 10.1038/labinvest.2013.43. Epub 2013 Mar 4.

10.

Characterization of novel germline c-kit gene mutation, KIT-Tyr553Cys, observed in a family with multiple gastrointestinal stromal tumors.

Nakai M, Hashikura Y, Ohkouchi M, Yamamura M, Akiyama T, Shiba K, Kajimoto N, Tsukamoto Y, Hao H, Isozaki K, Hirai T, Hirota S.

Lab Invest. 2012 Mar;92(3):451-7. doi: 10.1038/labinvest.2011.165. Epub 2011 Nov 14.

11.

Prognosis of adult patients transplanted with liver grafts < 35% of their standard liver volume.

Ikegami T, Masuda Y, Ohno Y, Mita A, Kobayashi A, Urata K, Nakazawa Y, Miwa S, Hashikura Y, Miyagawa S.

Liver Transpl. 2009 Nov;15(11):1622-30. doi: 10.1002/lt.21716.

12.

Donor complications associated with living donor liver transplantation in Japan.

Hashikura Y, Ichida T, Umeshita K, Kawasaki S, Mizokami M, Mochida S, Yanaga K, Monden M, Kiyosawa K; Japanese Liver Transplantation Society.

Transplantation. 2009 Jul 15;88(1):110-4. doi: 10.1097/TP.0b013e3181aaccb0.

PMID:
19584689
13.

Early neonatal onset carbamoyl-phosphate synthase 1 deficiency treated with continuous hemodiafiltration and early living-related liver transplantation.

Ishida T, Hiroma T, Hashikura Y, Horiuchi M, Kobayashi K, Nakamura T.

Pediatr Int. 2009 Jun;51(3):409-10. doi: 10.1111/j.1442-200X.2009.02831.x. No abstract available.

PMID:
19500281
14.

Purification method using iodixanol (OptiPrep)-based density gradient significantly reduces cytokine chemokine production from human islet preparations, leading to prolonged beta-cell survival during pretransplantation culture.

Mita A, Ricordi C, Miki A, Barker S, Khan A, Alvarez A, Hashikura Y, Miyagawa S, Ichii H.

Transplant Proc. 2009 Jan-Feb;41(1):314-5. doi: 10.1016/j.transproceed.2008.10.059.

15.

Living donor liver transplantation for patients with fulminant hepatic failure.

Hashikura Y.

Hepatol Res. 2008 Nov;38 Suppl 1:S56-9. doi: 10.1111/j.1872-034X.2008.00428.x.

PMID:
19125954
16.

Arterial reconstruction in a case of subintimal dissection of celiac arterial tributaries in living donor liver transplantation: a case report.

Ikegami T, Masuda Y, Ohno Y, Urata K, Nakazawa Y, Miwa S, Hashikura Y, Miyagawa S.

Transplant Proc. 2008 Dec;40(10):3794-6. doi: 10.1016/j.transproceed.2008.06.083.

PMID:
19100493
17.

Anti-proinflammatory effects of sirolimus on human islet preparations.

Mita A, Ricordi C, Miki A, Barker S, Haertter R, Hashikura Y, Miyagawa S, Burke GW 3rd, Inverardi L, Ichii H.

Transplantation. 2008 Jul 15;86(1):46-53. doi: 10.1097/TP.0b013e31817c79c0.

18.

Living donor liver transplantation: issues regarding left liver grafts.

Hashikura Y, Kawasaki S.

HPB (Oxford). 2004;6(2):99-105. doi: 10.1080/13651820310020792.

19.

De novo autoimmune hepatitis following living-donor liver transplantation for primary biliary cirrhosis.

Yoshizawa K, Shirakawa H, Ichijo T, Umemura T, Tanaka E, Kiyosawa K, Imagawa E, Matsuda K, Hidaka E, Sano K, Nakazawa Y, Ikegami T, Hashikura Y, Miyagawa S, Ota M, Nakano M.

Clin Transplant. 2008 May-Jun;22(3):385-90. doi: 10.1111/j.1399-0012.2007.00787.x. Epub 2008 Jan 9.

PMID:
18190552
20.

Nonsurgical policy for treatment of bilioenteric anastomotic stricture after living donor liver transplantation.

Mita A, Hashikura Y, Masuda Y, Ohno Y, Urata K, Nakazawa Y, Ikegami T, Terada M, Yamamoto H, Miyagawa S.

Transpl Int. 2008 Apr;21(4):320-7. Epub 2007 Dec 5.

21.

Transthyretin-derived amyloid deposition on the gastric mucosa in domino recipients of familial amyloid polyneuropathy liver.

Takei Y, Gono T, Yazaki M, Ikeda S, Ikegami T, Hashikura Y, Miyagawa S, Hoshii Y.

Liver Transpl. 2007 Feb;13(2):215-8.

22.

Risk factors contributing to hepatic artery thrombosis following living-donor liver transplantation.

Ikegami T, Hashikura Y, Nakazawa Y, Urata K, Mita A, Ohno Y, Terada M, Miyagawa S, Kushima H, Kondoh S.

J Hepatobiliary Pancreat Surg. 2006;13(2):105-9.

PMID:
16547670
23.

Characterization of cytochrome P450 expression in murine embryonic stem cell-derived hepatic tissue system.

Tsutsui M, Ogawa S, Inada Y, Tomioka E, Kamiyoshi A, Tanaka S, Kishida T, Nishiyama M, Murakami M, Kuroda J, Hashikura Y, Miyagawa S, Satoh F, Shibata N, Tagawa Y.

Drug Metab Dispos. 2006 Apr;34(4):696-701. Epub 2006 Jan 13.

PMID:
16415121
24.

Ten years of experience with liver transplantation for familial amyloid polyneuropathy in Japan: outcomes of living donor liver transplantations.

Takei Y, Ikeda S, Ikegami T, Hashikura Y, Miyagawa S, Ando Y; Japanese Liver Transplantation Society.

Intern Med. 2005 Nov;44(11):1151-6.

25.

Expression of Fas ligand by hepatic macrophages in patients with fulminant hepatic failure.

Mita A, Hashikura Y, Tagawa Y, Nakayama J, Kawakubo M, Miyagawa S.

Am J Gastroenterol. 2005 Nov;100(11):2551-9.

PMID:
16279913
26.

Crucial roles of mesodermal cell lineages in a murine embryonic stem cell-derived in vitro liver organogenesis system.

Ogawa S, Tagawa Y, Kamiyoshi A, Suzuki A, Nakayama J, Hashikura Y, Miyagawa S.

Stem Cells. 2005 Aug;23(7):903-13.

27.

MCI-186 (edaravone), a free radical scavenger, attenuates hepatic warm ischemia-reperfusion injury in rats.

Suzuki F, Hashikura Y, Ise H, Ishida A, Nakayama J, Takahashi M, Miyagawa S, Ikeda U.

Transpl Int. 2005 Jul;18(7):844-53.

28.

Domino liver transplantation in living donors.

Hashikura Y, Ikegami T, Nakazawa Y, Urata K, Mihara M, Mita A, Sakon M, Miyagawa S, Ikeda S.

Transplant Proc. 2005 Mar;37(2):1076-8.

PMID:
15848627
29.

Feasibility of auxiliary partial orthotopic liver transplantation from living donors for patients with adult-onset type II citrullinemia.

Yazaki M, Hashikura Y, Takei Y, Ikegami T, Miyagawa S, Yamamoto K, Tokuda T, Kobayashi K, Saheki T, Ikeda S.

Liver Transpl. 2004 Apr;10(4):550-4.

30.

Osteonecrosis of the femoral head in Japanese adults after liver transplantation: a preliminary report.

Horiuchi H, Hashikura Y, Hisa K, Saito N, Ikegami T, Nakazawa Y, Karakida O, Kobayashi S, Nawata M, Kawasaki S, Takaoka K.

J Orthop Sci. 2004;9(2):119-21.

PMID:
15045538
31.

Conversion from tacrolimus to cyclosporine microemulsion therapy in liver transplant recipients.

Ogino S, Hashikura Y, Katsuyama Y, Ikegami T, Nakazawa Y, Urata K, Terada M, Miyagawa S, Kawasaki S.

Transplant Proc. 2004 Mar;36(2 Suppl):299S-301S.

PMID:
15041357
32.

Delayed domino liver transplantation: use of the remnant liver of a recipient of a temporary auxiliary orthotopic liver transplant as a liver graft for another patient.

Hashikura Y, Ikegami T, Nakazawa Y, Urata K, Ogino S, Terada M, Miyagawa S, Kawasaki S, Takei Y, Ikeda S.

Transplantation. 2004 Jan 27;77(2):324. No abstract available.

PMID:
14743007
33.

Von Willebrand factor--cleaving protease activity in thrombotic microangiopathy after living donor liver transplantation: a case report.

Nakazawa Y, Hashikura Y, Urata K, Ikegami T, Terada M, Yagi H, Ishizashi H, Matsumoto M, Fujimura Y, Miyagawa S.

Liver Transpl. 2003 Dec;9(12):1328-33.

34.

Liver transplantation as treatment for neurological disorders.

Ikeda S, Takei Y, Hashikura Y.

Expert Rev Neurother. 2003 Jul;3(4):547-55. doi: 10.1586/14737175.3.4.547.

PMID:
19810938
35.

Living liver donation: preoperative assessment, anatomic considerations, and long-term outcome.

Chisuwa H, Hashikura Y, Mita A, Miyagawa S, Terada M, Ikegami T, Nakazawa Y, Urata K, Ogino S, Kawasaki S.

Transplantation. 2003 May 27;75(10):1670-6.

PMID:
12777854
36.

Peripheral nerve function in patients with familial amyloid polyneuropathy after liver transplantation.

Kobayashi S, Morita H, Asawa T, Takei Y, Hashimoto T, Ikegami T, Hashikura Y, Kawasaki S, Ikeda S.

Amyloid. 2003 Mar;10(1):17-24.

PMID:
12762137
37.

Life-threatening veno-occlusive disease after living-related liver transplantation.

Nakazawa Y, Chisuwa H, Mita A, Ikegami T, Hashikura Y, Terada M, Nakayama J, Kawasaki S.

Transplantation. 2003 Mar 15;75(5):727-30.

PMID:
12640317
38.

[Infection in liver transplant recipients].

Hashikura Y, Kawasaki S.

Nihon Geka Gakkai Zasshi. 2002 Dec;103(12):877-9. Review. Japanese.

PMID:
12599927
39.

[Liver transplantation for fulminant hepatic failure].

Hashikura Y, Kawasaki S.

Nihon Shokakibyo Gakkai Zasshi. 2002 Aug;99(8):913-6. Review. Japanese. No abstract available.

PMID:
12229163
40.

Usefulness of albumin scintigraphy in a pediatric liver transplant recipient with gastrointestinal posttransplant lymphoproliferative disorder.

Mita A, Hashikura Y, Momose M, Nakayama J, Sasaki E, Ikegami T, Nakazawa Y, Chisuwa H, Terada M, Kawasaki S.

Liver Transpl. 2002 Jun;8(6):568-9. No abstract available.

41.

Temporary auxiliary liver transplantation from a living donor to an adult recipient with familial amyloid polyneuropathy.

Ikegami T, Kawasaki S, Ohno Y, Chisuwa H, Urata K, Nakazawa Y, Hashikura Y, Terada M, Miyagawa S, Takei Yi Y, Tokuda T, Ikeda Si S.

Transplantation. 2002 Feb 27;73(4):628-30.

PMID:
11889444
42.

Recent advance in living donor liver transplantation.

Hashikura Y, Kawasaki S, Miyagawa S, Terada M, Ikegami T, Nakazawa Y, Urata K, Chisuwa H, Ogino S, Makuuchi M.

World J Surg. 2002 Feb;26(2):243-6. Epub 2001 Dec 17.

PMID:
11865355
43.

[Liver transplantation].

Hashikura Y, Kawasaki S.

Nihon Rinsho. 2002 Jan;60 Suppl 1:696-702. Review. Japanese. No abstract available.

PMID:
11838186
44.

Primary sclerosing cholangitis complicated with idiopathic thrombocytopenic purpura.

Sakai M, Egawa N, Sakamaki H, Sanaka M, Yuyang T, Kamisawa T, Sakaki N, Funata N, Nakazawa Y, Ikegami T, Hashikura Y, Kawasaki S.

Intern Med. 2001 Dec;40(12):1209-14.

45.

Gastric volvulus in living, related liver transplantation donors and usefulness of endoscopic correction.

Akamatsu T, Nakamura N, Kiyosawa K, Ikegami T, Hashikura Y, Miyagawa S, Kawasaki S.

Gastrointest Endosc. 2002 Jan;55(1):55-7.

PMID:
11756915
46.

Fatal hemophagocytic syndrome after living-related liver transplantation: a report of two cases.

Chisuwa H, Hashikura Y, Nakazawa Y, Kamijo T, Nakazawa K, Nakayama J, Oh-Ishi T, Ikegami T, Terada M, Kawasaki S.

Transplantation. 2001 Dec 15;72(11):1843-6.

PMID:
11740400
47.

Type II (adult onset) citrullinaemia: clinical pictures and the therapeutic effect of liver transplantation.

Ikeda S, Yazaki M, Takei Y, Ikegami T, Hashikura Y, Kawasaki S, Iwai M, Kobayashi K, Saheki T.

J Neurol Neurosurg Psychiatry. 2001 Nov;71(5):663-70.

48.

Long-term results of living-related donor liver graft transplantation: a single-center analysis of 110 transplants.

Hashikura Y, Kawasaki S, Terada M, Ikegami T, Nakazawa Y, Urata K, Chisuwa H, Mita A, Ohno Y, Miyagawa S.

Transplantation. 2001 Jul 15;72(1):95-9.

PMID:
11468541
49.
50.

["Domino" transplantation].

Ikegami T, Ogawa S, Ogino S, Wada Y, Ono Y, Chisuwa H, Urata K, Nakazawa Y, Hashikura Y, Terada M, Miyagawa S, Kawasaki S.

Nihon Naika Gakkai Zasshi. 2001 Jan 10;90(1):15-20. Review. Japanese. No abstract available.

PMID:
11215465

Supplemental Content

Loading ...
Support Center